GUCY2C and neoplasm: The adenovirus 5/F35-human guanylyl cyclase C-PADRE (Ad5.F35-hGCC-PADRE) vaccine may help train the patient’s own immune system to identify and kill tumor cells and prevent them from forming recurrences and metastases.